Meta-analysis of 15 studies (5440 adults with DLBCL on first-line R-CHOP-based therapy): pooled febrile neutropenia incidence was 19.0% in 10 observational cohorts vs 11.7% in 5 heterogeneous trials; the design difference was not significant (p=0.051).
Meta-analysisn = 5,440
Reyes et al. Febrile neutropenia in adults with diffuse large B-cell lymphoma receiving first-line R-CHOP-based therapy: a systematic review and meta-analysis of observational and trial evidence